MTOR and cancer: We found that along with KLF4 suppression, p110δ, a catalytic subunit of PI3K in cancer [20], Akt and mTOR (another identified target of miR-7 [9]) were significantly down-regulated in PC3-miR-7 cells and its derived xenografts (Figure 5A and 5B).